FDA Inspection 1297380 — Biomat USA, Inc

Biomat USA, Inc — FEI 3005488132

The FDA completed an inspection of Biomat USA, Inc on Dec 12, 2025 in City Of Industry, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 12, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
City Of Industry, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.